NAFDAC STEPS UP CLAMP DOWN ON FALSIFIED MEDICAL PRODUCTS

The National Agency for Food and Drugs Administration and Control (NAFDAC) intensifies its efforts to combat the
proliferation of falsified medical products in Nigeria. Professor Mojisola Adeyeye, the Director General of NAFDAC,
discloses a startling revelation that more than half of the medicines and medical ingredients imported into the
country fall under the category of substandard or falsified.

Highlighting the gravity of the situation, Professor Adeyeye points fingers at the pharmaceutical companies in
India and China, alleging collusion with importers to jeopardize the health of Nigerians. She asserts a firm
commitment to curbing the circulation of counterfeit medicines by reinforcing pre-shipment testing measures.

Furthermore, Professor Adeyeye underscores the urgent need for stringent regulatory measures to address this
grave concern. She emphasizes the critical role of pre-shipment testing in safeguarding public health and ensuring
the quality and efficacy of medical products reaching Nigerian consumers.

In her statement, Professor Adeyeye expresses resolve in tackling this pressing issue head-on, signaling NAFDAC’s
unwavering commitment to protecting the well-being of the populace. The agency’s intensified crackdown on falsified
 medical products reflects a proactive approach to addressing a significant threat to public health and safety in
 Nigeria.

Moreover, Professor Adeyeye highlights the imperative for collaborative efforts between regulatory bodies, law
enforcement agencies, and international partners to combat the proliferation of counterfeit medicines effectively.
 She stresses the importance of information sharing, capacity building, and coordinated enforcement actions to
dismantle illicit networks engaged in the production and distribution of substandard and falsified medical products.

In her address, Professor Adeyeye reiterates NAFDAC’s commitment to upholding the highest standards of regulatory
oversight and enforcement. She underscores the agency’s dedication to ensuring that only safe, efficacious,
and quality medical products are available to the Nigerian populace, thereby safeguarding public health and
promoting trust in the healthcare system.